Pharmaceutical company BioNTech announced Wednesday it had agreed to supply additional 200 million doses of its coronavirus vaccine to the European Commission, which also has the option to request a further 100 million doses. Pročitaj više
| /
Pharmaceutical company BioNTech announced Wednesday it had agreed to supply additional 200 million doses of its coronavirus vaccine to the European Commission, which also has the option to request a further 100 million doses. Pročitaj više